FDA Approves Two Drugs (Esbriet, Ofev) for Treating Fatal Lung Disease

October 16, 2014 11:55 PM

5 0

The two drugs which have won the approval of the FDA are- Roche’s Esbriet and Boehringer Ingelheim’s Ofev. Both are meant to treat idiopathic pulmonary fibrosis, a condition which affects over 100,000 Americans. Many of them are killed in three to five years. The drug does not cure the patient but arrests the decline of lung functions in some patients.

Daniel M. Rose, chief executive of the Pulmonary Fibrosis Foundation, an advocacy group that gets some funding from drug companies said, “It’s very exciting to have two approved therapies now for a disease for which there were no approved therapies. There’s a lot of enthusiasm and excitement within ...

Read more

To category page